Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer

NCT00405938 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Breast Neoplasms

Interventions

DRUG: Bevacizumab
DRUG: Anastrozole
DRUG: Fulvestrant

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]